Trails Edge Capital Partners, LP - 18 Feb 2026 SCHEDULE 13G Report for Sensei Biotherapeutics, Inc. Common Shares, no par value per share (SNSE)

Filing Manager: Trails Edge Capital Partners, LP
Reporting Manager: Trails Edge Capital Partners, LP
Security: Sensei Biotherapeutics, Inc. Common Shares, no par value per share
Symbol: SNSE
Shares outstanding: 1,272,828 shares
Disclosed Ownership: 126,010 shares
Ownership: 9.9%
Form type: SCHEDULE 13G
Filing time: 25 Feb 2026, 16:15:07 UTC
Date of event: 18 Feb 2026
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Trails Edge Capital Partners, LP	9.9%	126,010	126,010	/s/ Trails Edge Capital Partners, LLC, GP of Trails Edge Capital Partners, LP /s/ Ortav Yehudai	Ortav Yehudai / Chief Investment Officer of Trails Edge Capital Partners, LLC
Trails Edge Biotechnology Master Fund, LP	9.9%	126,010	126,010	/s/ Trails Edge GP, LLC, GP of Trails Edge Biotechnology Fund GP, LP, GP of Trails Edge Biotechnology Master Fund, LP /s/ Ortav Yehudai	Ortav Yehudai / Chief Investment Officer of Trails Edge GP, LLC
Ortav Yehudai	9.9%	126,010	126,010	/s/ Ortav Yehudai	Ortav Yehudai / Individual